TMO
Thermo Fisher Scientific Inc.
Stock
$675.05−4.56 (−0.67%)Close Sep 30, 2026
| Revenue (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $46.3B | +7.2% | 6.7% | 10.1% |
| Revenue (TTM) | $46.3B |
|---|---|
| YoY | +7.2% |
| 5-year CAGR | 6.7% |
| 10-year CAGR | 10.1% |
Revenue
| Period | Revenue | YoY |
|---|---|---|
| 2025 | $44.6B | +3.9% |
| 2024 | $42.9B | +0.1% |
| 2023 | $42.9B | −4.6% |
| 2022 | $44.9B | +14.5% |
| 2021 | $39.2B | +21.7% |
| 2020 | $32.2B | +26.1% |
| 2019 | $25.5B | +4.9% |
| 2018 | $24.4B | +16.4% |
| 2017 | $20.9B | +14.5% |
| 2016 | $18.3B | +7.7% |
| 2015 | $17.0B | +0.4% |
| 2014 | $16.9B | +29.0% |
| 2013 | $13.1B | +4.6% |
| 2012 | $12.5B | +8.2% |
| 2011 | $11.6B | +11.2% |
| 2010 | $10.4B | +4.9% |
| 2009 | $9.9B | −5.6% |
| 2008 | $10.5B | +7.7% |
| 2007 | $9.7B | — |